NO20030213L - Anvendelse av D2/D3 reseptor-agonister for behandling av fibr omyalgi - Google Patents

Anvendelse av D2/D3 reseptor-agonister for behandling av fibr omyalgi

Info

Publication number
NO20030213L
NO20030213L NO20030213A NO20030213A NO20030213L NO 20030213 L NO20030213 L NO 20030213L NO 20030213 A NO20030213 A NO 20030213A NO 20030213 A NO20030213 A NO 20030213A NO 20030213 L NO20030213 L NO 20030213L
Authority
NO
Norway
Prior art keywords
fibromyalgia
treatment
receptor agonists
agonists
receptor
Prior art date
Application number
NO20030213A
Other languages
English (en)
Other versions
NO20030213D0 (no
Inventor
Andrew J Holman
Original Assignee
Andrew J Holman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andrew J Holman filed Critical Andrew J Holman
Publication of NO20030213D0 publication Critical patent/NO20030213D0/no
Publication of NO20030213L publication Critical patent/NO20030213L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20030213A 2000-07-17 2003-01-16 Anvendelse av D2/D3 reseptor-agonister for behandling av fibr omyalgi NO20030213L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/617,177 US6277875B1 (en) 2000-07-17 2000-07-17 Use of dopamine D2/D3 receptor agonists to treat fibromyalgia
PCT/US2001/021530 WO2002005797A2 (en) 2000-07-17 2001-07-05 Use of dopamine d2/d3 receptor agonists to treat fibromyalgia

Publications (2)

Publication Number Publication Date
NO20030213D0 NO20030213D0 (no) 2003-01-16
NO20030213L true NO20030213L (no) 2003-03-11

Family

ID=24472575

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030213A NO20030213L (no) 2000-07-17 2003-01-16 Anvendelse av D2/D3 reseptor-agonister for behandling av fibr omyalgi

Country Status (17)

Country Link
US (2) US6277875B1 (no)
EP (1) EP1311251A2 (no)
JP (1) JP2004503587A (no)
KR (1) KR100797603B1 (no)
CN (1) CN1443066A (no)
AU (2) AU2001271910B2 (no)
BR (1) BR0112476A (no)
CA (1) CA2414774C (no)
CZ (1) CZ2003417A3 (no)
HU (1) HUP0301305A3 (no)
IL (1) IL153915A0 (no)
MX (1) MXPA03000336A (no)
NO (1) NO20030213L (no)
NZ (1) NZ523926A (no)
PL (1) PL360121A1 (no)
WO (1) WO2002005797A2 (no)
ZA (1) ZA200300588B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020089510A (ko) * 2000-04-21 2002-11-29 파마시아 앤드 업존 캄파니 섬유 근육통 증후군 및 만성 피로 증후군의 치료
DE10041479A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
US20020165246A1 (en) * 2001-03-05 2002-11-07 Andrew Holman Administration of sleep restorative agents
DE10137162A1 (de) * 2001-07-30 2003-02-20 Hexal Ag Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
GB0125088D0 (en) * 2001-10-18 2001-12-12 Smithkline Beecham Cork Ltd New use
US7079888B2 (en) * 2002-04-11 2006-07-18 Ansar, Inc. Method and apparatus for monitoring the autonomic nervous system using non-stationary spectral analysis of heart rate and respiratory activity
US20040048779A1 (en) * 2002-05-06 2004-03-11 Erwin Schollmayer Use of rotigotine for treating the restless leg syndrome
MY142204A (en) * 2002-07-25 2010-10-29 Pharmacia Corp Pramipexole once-daily dosage form
MY136318A (en) * 2002-07-25 2008-09-30 Pharmacia Corp Sustained-release tablet composition
US20050226926A1 (en) * 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
US20040092504A1 (en) * 2002-11-12 2004-05-13 Anuthep Benja-Athon Definitive medications for treating fibromyalgia
SI1426049T1 (en) * 2002-12-02 2005-08-31 Sanol Arznei Schwarz Gmbh Iontophoretic delivery of rotigotine for the treatment of Parkinson's disease
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
EP2431026A1 (en) * 2004-08-13 2012-03-21 Boehringer Ingelheim International GmbH Extended release pellet formulation containing Pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
BRPI0513846A (pt) * 2004-08-13 2008-05-20 Boehringer Ingelheim Int formulação de comprimido de liberação prolongada contendo pramipexol ou um sal farmaceuticamente aceitável do mesmo, método para a fabricação do mesmo e o uso do mesmo
WO2007048034A2 (en) * 2005-10-21 2007-04-26 Caritas St. Elizabeth Medical Center Of Boston, Inc. Use of androgens for the treatment of parkinson' s disease
US20090098202A1 (en) * 2006-02-10 2009-04-16 Boehringer Ingelheim International Gmbh Extended Release Formulation
WO2007090881A2 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Modified release formulation
TWI392670B (zh) * 2006-06-22 2013-04-11 Ucb Pharma Gmbh 經取代的２-胺基萘滿之於製造用於預防、減緩及／或治療各種類型疼痛之藥物上的用途
CN1944647B (zh) * 2006-08-23 2010-05-12 华东师范大学 多巴胺受体新亚型d5b基因及编码的蛋白与应用
GB0700786D0 (en) * 2007-01-15 2007-02-21 Pfizer Ltd Morpholine dopamine agonists for the treatment of pain
EP1987815A1 (en) * 2007-05-04 2008-11-05 Schwarz Pharma Ag Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders
US20110195117A1 (en) * 2008-09-01 2011-08-11 Lupin Limited Controlled release compositions of ropinirole
CA2738414C (en) 2008-09-29 2014-05-27 Wockhardt Research Centre Extended release dosage form of ropinirole
WO2010044108A2 (en) 2008-10-17 2010-04-22 Rubicon Research Private Limited Controlled release formulations of ropinirole
KR20120137373A (ko) 2010-04-30 2012-12-20 테이코쿠 팔마 유에스에이, 인코포레이티드 프로필아미노인단 경피 조성물
CN103476404B (zh) 2011-03-24 2017-09-29 帝国制药美国公司 包含活性剂层和活性剂转化层的透皮组合物
EP2776020B1 (en) 2011-11-09 2019-09-11 Teikoku Seiyaku Co., Ltd. Methods for the treatment of skin neoplasms
MX366649B (es) 2012-11-02 2019-07-17 Teikoku Seiyaku Kk Composiciones transdérmicas de propinilaminoindan.
MA41125A (fr) 2014-12-05 2017-10-10 Purdue Pharma Lp Dérivés de 6.7-cyclomorphinane et leur utilisation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4414224A (en) * 1980-08-22 1983-11-08 Smithkline Beckman Corporation Pharmaceutical composition and methods for producing dopamine agonist activity
US4879391A (en) * 1982-09-20 1989-11-07 Pfizer Inc. 1-Phenyl-2(1H,3H)-indolone psychotherapeutic agents
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
DE3447075A1 (de) * 1984-12-22 1986-07-03 Dr. Karl Thomae Gmbh, 7950 Biberach Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arzneimittel
DE3572485D1 (en) * 1984-12-22 1989-09-28 Thomae Gmbh Dr K Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs
GB8712073D0 (en) * 1987-05-21 1987-06-24 Smith Kline French Lab Medicament
US5498610A (en) * 1992-11-06 1996-03-12 Pfizer Inc. Neuroprotective indolone and related derivatives
US5696128A (en) 1994-07-07 1997-12-09 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method of regulating immune function
US5658955A (en) 1994-11-01 1997-08-19 Hitzig; Pietr Combined use of dopamine and serotonin agonists in the treatment of immune disorders
KR20020089510A (ko) * 2000-04-21 2002-11-29 파마시아 앤드 업존 캄파니 섬유 근육통 증후군 및 만성 피로 증후군의 치료

Also Published As

Publication number Publication date
AU2001271910B2 (en) 2005-07-28
MXPA03000336A (es) 2005-04-19
CN1443066A (zh) 2003-09-17
HUP0301305A2 (hu) 2003-08-28
WO2002005797A2 (en) 2002-01-24
KR100797603B1 (ko) 2008-01-28
WO2002005797A8 (en) 2003-03-06
US6277875B1 (en) 2001-08-21
US6300365B1 (en) 2001-10-09
CZ2003417A3 (cs) 2003-08-13
ZA200300588B (en) 2004-04-22
IL153915A0 (en) 2003-07-31
NO20030213D0 (no) 2003-01-16
JP2004503587A (ja) 2004-02-05
PL360121A1 (en) 2004-09-06
BR0112476A (pt) 2003-07-22
AU7191001A (en) 2002-01-30
EP1311251A2 (en) 2003-05-21
KR20030029625A (ko) 2003-04-14
HUP0301305A3 (en) 2008-03-28
CA2414774A1 (en) 2002-01-24
CA2414774C (en) 2010-09-07
NZ523926A (en) 2006-05-26

Similar Documents

Publication Publication Date Title
NO20030213L (no) Anvendelse av D2/D3 reseptor-agonister for behandling av fibr omyalgi
DE69939396D1 (de) Verfahren für das ausdehnen des gebrauches des sip protokolls
DE69936767D1 (de) Patientenmonitor
EE200400025A (et) 5-HT retseptori ligandid ja nende kasutamine
DK1112106T3 (da) Serotonerge 5HT2-agonister til behandling af glaukom
IS5699A (is) Ný notkun
EE200300239A (et) Rosuvastatiini (ZD4522) kasutamine heterosügootseperekondliku hüperkolesteroleemia raviks
ZA200305691B (en) The use of substituted azetidione compounds for the treatment of sitosterolemia
FI20000863A (fi) Uusi hoitomenetelmä
DE60226578D1 (de) Chirurgische greifvorrichtung
HK1068551A1 (en) Substituted benzimidazole compounds and their use for the treatment of cancer
PT1206436E (pt) Retinoides para o tratamento de enfisema
NO20005386D0 (no) Anvendelse av NMDA-antagonister for behandling av irritabel tarmsyndrom
NO20043113L (no) Fremgangsmate for behandling av benforstyrrelse
PT1176991E (pt) Dispositivo ceramico para tratamento de feridas
DE60008489D1 (de) Lösbarer Endanschlag
ID30381A (id) Penggunaan arilalkanoilpiridazina
NO20022142D0 (no) Anvendelse av dopamin-D3 reseptor agonister for behandling av saltavhengig hypertensjon
SE9801673D0 (sv) New medical use of substituted quinolines
DE60232185D1 (de) System zur verwaltung des herzrhythmus
DE50006327D1 (de) Vorrichtungen zur versorgung autarker gebäude
NO20011189L (no) Innretning for behandling av suspensjoner
NO996166L (no) FremgangsmÕte for behandling av avluter
FI20002756A0 (fi) Uusi hoitomenetelmä
IT1309614B1 (it) Attrezzatura per la fabbricazione di fiocchi - coccarde per usodecorativo

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application